School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan.
Molecules. 2020 Oct 8;25(19):4586. doi: 10.3390/molecules25194586.
This study describes the antiproliferative and antimigration effects of beauvericin from a culture broth of sp. in human pancreatic cancer cells (PANC-1). Activity-guided fractionation of the EtOAc extract of cultured broth of sp. RD055140 afforded beauvericin (), a new isariotin derivative, 7--methylisariotin C (), together with the known isariotin analogs, TK-57-164A () and B (). As a result of the measurement of the cell viability, inhibited cell growth (IC = 4.8 µM) of PANC-1 cells. Furthermore, was found to inhibit the migration activity of PANC-1 cells by upregulating the expression of the gene and reducing and genes in a dose-dependent manner (0.1-1 µM). These activities of had lower concentrations than the cytotoxic activity. These findings suggest that can be used as an anticancer agent against human pancreatic carcinoma.
本研究描述了从 sp. 的培养肉汤中分离出的 beauvericin 对人胰腺癌细胞(PANC-1)的抗增殖和抗迁移作用。对 sp. RD055140 培养肉汤的 EtOAc 提取物进行活性导向分离,得到 beauvericin (),一种新的 isariotin 衍生物,7--甲基异齿菌素 C (),以及已知的异齿菌素类似物,TK-57-164A () 和 B ()。由于细胞活力的测量,抑制了 PANC-1 细胞的生长(IC = 4.8 µM)。此外,发现通过上调基因的表达,并以剂量依赖的方式降低基因和基因(0.1-1 µM),抑制了 PANC-1 细胞的迁移活性。与细胞毒性活性相比,的这些活性具有更低的浓度。这些发现表明,可作为一种针对人类胰腺癌的抗癌药物。